柴田雅央

シバタマサヒロ | Shibata Masahiro

所属機関・部署：
職名：助教

研究分野 (1件)：外科学一般、小児外科学

研究キーワード (6件)：バイオマーカー , 上皮小体 , 副甲状腺 , 副腎腫瘍 , 甲状腺癌 , 乳癌

論文 (29件)：

Watanabe M, Shibata M, Inaishi T, Ichikawa T, Soeda I, Miyajima N, Takano Y, Takeuchi D, Tsunoda N, Kanda M, et al. MZB1 expression indicates poor prognosis in estrogen receptor-positive breast cancer. Oncology letters. 2020. 20. 5. 198-198
Shibata M, Ooki A, Inokawa Y, Sadhukhan P, Ugurlu MT, Izumchenko E, Munari E, Bogina G, Rudin CM, Gabrielson E, et al. Concurrent Targeting of Potential Cancer Stem Cells Regulating Pathways Sensitizes Lung Adenocarcinoma to Standard Chemotherapy. Molecular cancer therapeutics. 2020. 19. 10. 2175-2185
Shizuku Masato, Shibata Masahiro, Shimizu Yoshimi, Takeuchi Dai, Mizuno Yutaka. Clinical outcomes of neoadjuvant chemotherapy for patients with breast cancer: Tri-weekly nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide: a retrospective observational study. NAGOYA JOURNAL OF MEDICAL SCIENCE. 2020. 82. 3. 457-467
Shizuku M, Shibata M, Okumura M, Takeuchi D, Kikumori T, Mizuno Y. Utility of urinary type I collagen cross-linked N-telopeptide as a prognostic indicator in breast cancer patients with bone metastases. Breast cancer (Tokyo, Japan). 2020
Kikumori T, Ichikawa T, Inaishi T, Miyajima N, Shibata M, Takeuchi D. Measurement of the AST to LD ratio in parathyroid tissue suspension can precisely differentiate a hyperfunctioning parathyroid. The Journal of clinical endocrinology and metabolism. 2020

MISC (18件)：

Shibata M. RASEF expression correlates with hormone receptor status in breast cancer. Oncology Letters. 2018. 16. 6. 7223-7230-7230
Shibata M, Ham K, Hoque MO. A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy. International journal of cancer. 2018. 143. 9. 2133-2144
Tanaka Haruyoshi, Kanda Mitsuro, Miwa Takashi, Tanaka Chie, Kobayashi Daisuke, Umeda Shinichi, Shibata Masahiro, Suenaga Masaya, Hattori Norifumi, Hayashi Masamichi, et al. Pattern-Specific Transcriptomics Identifies ASGR2 as a Predictor of Hematogenous Recurrence of Gastric Cancer. MOLECULAR CANCER RESEARCH. 2018. 16. 9. 1420-1429-1429
Shibata M, Hoque MO. Development of biomarkers for real precision medicine. Translational lung cancer research. 2018. 7. Suppl 3. S228-S231
Takahiro Inaishi, Toyone Kikumori, Dai Takeuchi, Hiromasa Ishihara, Noriyuki Miyajima, Masahiro Shibata, Yuko Takano, Kenichi Nakanishi, Sumiyo Noda, Yasuhiro Kodera. Obesity does not affect peri- and postoperative outcomes of transabdominal laparoscopic adrenalectomy. Nagoya Journal of Medical Science. 2018. 80. 1. 21-28

学歴 (2件)：

学位 (1件)：

経歴 (9件)：

2020/04/01 - 現在名古屋大学医学部附属病院乳腺・内分泌外科助教
2018/10/01 - 現在名古屋大学医学部附属病院乳腺・内分泌外科病院助教
2018/10/01 - 2020/03/31 名古屋大学医学部附属病院乳腺・内分泌外科病院助教
2016/10/01 - 2018/09/18 Johns Hopkins University Department of Otolaryngology Postdoctoral Fellow
2015/01/01 - 2016/09/30 名古屋大学医学部附属病院乳腺・内分泌外科医員

全件表示

所属学会 (11件)：

日本臨床外科学会 , 日本東洋医学会 , 日本内視鏡外科学会 , 日本がん治療学会 , 日本甲状腺学会 , 日本乳腺甲状腺超音波医学会 , 日本内分泌学会 , 日本内分泌外科学会 , 日本乳癌検診学会 , 日本乳癌学会 , 日本外科学会

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

柴田 雅央